跳至主要内容
临床试验/JPRN-jRCT1030230068
JPRN-jRCT1030230068尚未招募Unknown

A preliminary study to investigate the efficacy of urinary syndecan-1 as a marker of glycocalyx collapsing and subsequential vascular endothelial infringement in patients with sepsis - PIE US-1M VIPS

Tazawa Kazumasa0 个研究点目标入组 24 人开始时间: 2023年5月14日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Sepsis and septic shock patients who need crinical care at general intensive care unit ( GICU) in our institution.
  • Define of sepsis: Infection diagnoted or suspected, with organ dysfunction with acute elevation of SOFA score over two points.
  • Define of septic shock: Sepsis with high blood lactate acid above 2 mmol/L (18 mg/dL), and need vasocontractive drug in addition to fluid resuscitation to keep mean arterial blood bressure over 65 mmHg.

排除标准

  • Patients who are not gotten concented, not available to insert cathetel into bladder, not available to take urea, emergent and obvious critical life- threatning situation, and have any possiblity to effect this study.

研究者

发起方
Tazawa Kazumasa

相似试验